Michael Kundi

24.2k total citations · 1 hit paper
476 papers, 15.0k citations indexed

About

Michael Kundi is a scholar working on Epidemiology, Infectious Diseases and Health, Toxicology and Mutagenesis. According to data from OpenAlex, Michael Kundi has authored 476 papers receiving a total of 15.0k indexed citations (citations by other indexed papers that have themselves been cited), including 77 papers in Epidemiology, 67 papers in Infectious Diseases and 67 papers in Health, Toxicology and Mutagenesis. Recurrent topics in Michael Kundi's work include Carcinogens and Genotoxicity Assessment (48 papers), Air Quality and Health Impacts (34 papers) and Vector-borne infectious diseases (29 papers). Michael Kundi is often cited by papers focused on Carcinogens and Genotoxicity Assessment (48 papers), Air Quality and Health Impacts (34 papers) and Vector-borne infectious diseases (29 papers). Michael Kundi collaborates with scholars based in Austria, Germany and United States. Michael Kundi's co-authors include Siegfried Knasmüller, Hanns Moshammer, Hans‐Peter Hutter, Peter Wallner, Heidemarie Holzmann, Stephan W. Aberle, Herwig Kollaritsch, Armen Nersesyan, Franz X. Heinz and Judith H. Aberle and has published in prestigious journals such as The Lancet, Nature Communications and Blood.

In The Last Decade

Michael Kundi

463 papers receiving 14.3k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Use and acceptance of complementary and alternative medicine among the general population and medical personnel: a systematic review.

2012 412 citations Michael Kundi et al. PubMed profile →

Peers

Countries citing papers authored by Michael Kundi

Since Specialization

Citations

This map shows the geographic impact of Michael Kundi's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Michael Kundi with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Michael Kundi more than expected).

Fields of papers citing papers by Michael Kundi

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Michael Kundi. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Michael Kundi. The network helps show where Michael Kundi may publish in the future.

Co-authorship network of co-authors of Michael Kundi

This figure shows the co-authorship network connecting the top 25 collaborators of Michael Kundi. A scholar is included among the top collaborators of Michael Kundi based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Michael Kundi. Michael Kundi is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Seroprevalence against measles, Austria, stratified by birth years 1922 to 2024 2025 ·Eurosurveillance ·(unknown), (unknown), Jeremy V. Camp, Monika Redlberger‐Fritz, Heidemarie Holzmann, Michael Kundi, Judith H. Aberle, Karin Stiasny, Lukas Weseslindtner	3
2	Recombinant Hypoallergenic Cat Allergy Vaccines 2025 ·Allergy ·(unknown), Mirela Curin, Margarete Focke‐Tejkl, (unknown), (unknown), Pia Gattinger, Marianne van Hage, Hans Grönlund, Renáta Kiss, Huey‐Jy Huang, Walter Keller, Ksenja Riabova, Antonina Karsonova, Michael Kundi, Inna Tulaeva, Daria Fomina, А. В. Караулов, Rudolf Valenta	2
3	A comparative study of digital and conventional occlusal indicators: accuracy and reliability of the T-Scan Novus, wax occlusogram, and articulating silk in clinical application 2025 ·Journal of Dentistry ·(unknown), (unknown), (unknown), Eva Piehslinger, Stefan Lettner, Michael Kundi, (unknown)	2
4	Is the T2MR Candida Panel a suitable alternative to the SeptiFast for the rapid diagnosis of candidemia in routine clinical practice? 2024 ·Clinical Microbiology and Infection ·(unknown), (unknown), Brigitte Selitsch, (unknown), (unknown), (unknown), Barbara Steinlechner, Johannes Weber, Peter Schellongowski, Christian Zauner, Gürkan Sengölge, Tamara Seitz, Alexander Zoufaly, (unknown), (unknown), Cornelia Lass‐Flörl, Heinz Burgmann, Michael Kundi, Birgit Willinger	5
5	The cytoskeletal protein profilin is an important allergen in saltwort (Salsola kali) 2024 ·Frontiers in Immunology ·(unknown), (unknown), Pia Gattinger, Margarete Focke‐Tejkl, Victoria Garib, (unknown), (unknown), (unknown), (unknown), Bülent Enis Şekerel, (unknown), (unknown), Michael Kundi, Walter Keller, А. В. Караулов, Rudolf Valenta	1
6	Abstract CT215: Frontline vaccination with the B-cell peptide compound HER-Vaxx (IMU-131), combined with standard-of-care chemotherapy induces high levels of HER2-specific antibodies mediating ADCC and intracellular phosphorylation inhibition resulting in overall survival benefit in patients with HER2+ metastatic or advanced gastric/GEJ adenocarcinoma - Final results from Phase II/HERIZON study 2024 ·Cancer Research ·Joshua Tobias, Michael Kundi, Erika Garner‐Spitzer, Christoph Zielinski, (unknown), Zoran Andrić, (unknown), Rajnish Nagarkar, (unknown), (unknown), (unknown), (unknown), Nicholas J. Ede, Ursula Wiedermann	1
7	The utilization of plants in traditional medicine and rituals of Karimunjawa Island community, Central Java, Indonesia 2024 ·Journal of Marine and Island Cultures ·(unknown), Michael Kundi, (unknown), Novel Lyndon, (unknown), (unknown), (unknown), (unknown)	0
8	Use of the single cell gel electrophoresis assay for the detection of DNA-protective dietary factors: Results of human intervention studies 2023 ·Mutation Research/Reviews in Mutation Research ·Miroslav Mišík, (unknown), Michael Kundi, (unknown), Armen Nersesyan, Franziska Ferk, Mária Dušinská, Amaya Azqueta, Peter Möller, Siegfried Knasmueller	8
9	Preclinical and Clinical Observations Implying Combination Therapy to Enhance the Efficacy of the Her-2/neu B-Cell Peptide-Based Vaccine HER-Vaxx and to Prevent Immune Evasion 2023 ·International Journal of Molecular Sciences ·Joshua Tobias, Sandra Högler, (unknown), (unknown), Yee Chao, Lukas Kenner, Erika Garner‐Spitzer, (unknown), Nicholas J. Ede, Christoph Zielinski, Michael Kundi, Ursula Wiedermann	1
10	Nonspecific symptoms following infection with Borrelia burgdorferi sensu lato: A retrospective cohort study 2021 ·Ticks and Tick-borne Diseases ·Mateusz Markowicz, Michael Kundi, Gerold Stanek, Hannes Stockinger	1
11	Significant impact of nationwide SARS-CoV-2 lockdown measures on the circulation of other respiratory virus infections in Austria 2021 ·Journal of Clinical Virology ·Monika Redlberger‐Fritz, Michael Kundi, Stephan W. Aberle, Elisabeth Puchhammer‐Stöckl	93
12	Atrophy of the central neuroretina in patients treated for diabetic macular edema 2019 ·Acta Ophthalmologica ·Sonja Karst, (unknown), Christoph Mitsch, Elias Laurin Meyer, Michael Kundi, Christoph Scholda, Ursula Schmidt‐Erfurth	12
13	CXCL13 concentrations in cerebrospinal fluid of patients with Lyme neuroborreliosis and other neurological disorders determined by Luminex and ELISA 2018 ·Ticks and Tick-borne Diseases ·Mateusz Markowicz, Anna‐Margarita Schötta, Michael Kundi, Petra Bogovič, Katarina Ogrinc, Franc Strle, Gerold Stanek	30
14	Comprehensive evaluation of chemiluminescent immunoassays for the laboratory diagnosis of Clostridium difficile infection 2017 ·European Journal of Clinical Microbiology & Infectious Diseases ·Athanasios Makristathis, Iris Zeller, Dieter Mitteregger, Michael Kundi, Alexander M. Hirschl	8
15	Xanthohumol Prevents DNA Damage by Dietary Carcinogens: Results of a Human Intervention Trial 2016 ·Cancer Prevention Research ·(unknown), Franziska Ferk, (unknown), Wolfgang Huber, Walter Jäger, (unknown), Miroslav Mišík, Michael Kundi, Armen Nersesyan, Irene Herbacek, Siegfried Knasmueller	26
16	Evaluation of a modular scalable system for silver-ager located in assisted living homes in Austria – study protocol of the ModuLAAr ambient assisted living project 2014 ·BMC Public Health ·Christian Siegel, (unknown), Johannes Kropf, Michael Kundi, Thomas E. Dorner	4
17	Semivolatile compounds in schools and their influence on cognitive performance of children 2013 ·International Journal of Occupational Medicine and Environmental Health ·Hans‐Peter Hutter, Daniela Haluza, (unknown), Philipp Hohenblum, Marina Fröhlich, Sigrid Scharf, Maria Uhl, (unknown), Peter Tappler, Michael Kundi, Peter Wallner, Hanns Moshammer	46
18	Comparative immunophenotypic analysis of human mast cells, blood basophils and monocytes 1996 ·Immunology ·Hermine Agis, Wolfgang Füreder, Hans Bankl, Michael Kundi, Wolfgang R. Sperr, Martin Willheim, G Boltz-Nitulescu, Joseph H. Butterfield, Kenji Kishi, Klaus Lechner, Peter Valent	117
19	Blood pressure responses after carotid surgery: Relationship to postoperative baroreceptor sensitivity 1993 ·The American Journal of Medicine ·Mirko Hirschl, Michael Kundi, Michael M. Hirschl, (unknown), D Magometschnigg	23
20	[Testmethod for the evaluation of procedures for the hygienic disinfection of hands. Part 1: Discription of testmethod (author's transl)]. 1977 ·PubMed ·M. Rotter, Walter Koller, Michael Kundi, G. Wewalka, H. Mittermayer	1

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact